Obstetrics/Gynecology
RSSArticles
-
Reproductive Health Is Important Among Communities with Opioid Use Disorder
Pregnancy-capable individuals with a history of opioid use disorder (OUD) hold an inherent distrust of the healthcare system. This is one reason why contraceptive counseling could be a challenge for this population. New research through Boston Medical Center shows that individuals with OUD exhibit similarities to individuals with other chronic medical conditions when they are choosing a contraceptive method. -
Research Shows Ultrasound Is Not Necessary for Medication Abortion
Researchers suggest reproductive health providers could offer patients a faster, less expensive medication abortion via telemedicine. Study findings show that omitting the pre-abortion ultrasound does not appear to compromise safety or result in more ongoing pregnancies. -
What Is New in Contraception?
The new editions of Contraceptive Technology and Managing Contraception include important updates to several forms of contraception, including progestin-only pills. -
Title X Program Saved by Biden Administration’s New Final Rule
Title X organizations and other groups praised the Biden administration for reversing the draconian changes to the Title X family planning program that were enacted in 2019 under the Trump administration. -
Effects of Texas Abortion Law Could Ripple Nationwide
The recent Texas law that banned abortions after six weeks gestation was written to be enforced by almost anyone, anywhere in the United States — creating a bounty hunter system. It could turn neighbors against neighbors, family members against family members, and incentivize strangers to spy on women. -
Safe and Legal Abortion Access Under Greatest Threat Since Roe v. Wade Decision
The largest and most damaging crack in the Roe v. Wade bulwark of abortion access was breached Sept. 1, when the U.S. Supreme Court’s inaction allowed the state of Texas to ban abortions after six weeks of gestation. There are no exceptions for rape or incest. The law gives about any person in the nation the right to sue the abortion provider and anyone else who assisted someone with abortion care. -
Updated 2021 Sexually Transmitted Infections Treatment Guidelines
The CDC updated their sexually transmitted infections treatment guidelines with new recommendations for Neisseria gonorrhoeae, Chlamydia trachomatis, Trichomonas vaginalis, pelvic inflammatory disease, and Mycoplasma genitalium.
-
COVID-19 Vaccination, Pregnancy, Lactation, and Fertility: What Should the OB/GYN Know?
With the increasing circulation of the Delta variant, it has become critically important for the OB/GYN to discuss COVID-19 vaccination with patients, and, specifically, to address concerns related to pregnancy, lactation, and fertility. This article reviews the most recent guidance from the American College of Obstetricians and Gynecologists, the Society of Maternal-Fetal Medicine, and the American Society for Reproductive Medicine on vaccination in reproductive-age individuals.
-
Vaginal Misoprostol vs. Prostaglandin E2 Pessary for Induction of Labor at Term
In this randomized, noninferiority, clinical trial of pregnant women who underwent induction of labor with misoprostol compared to dinoprostone, the rate of vaginal delivery within 24 hours was higher in the misoprostol group. Maternal satisfaction, assessed by a visual analog scale, also was higher. Although the noninferiority of dinoprostone to misoprostol could not be demonstrated, the clinical risk-to-benefit ratio justifies the use of both drugs.
-
Highlights from the CDC’s Updated 2021 Sexually Transmitted Infections Treatment Guidelines
The Centers for Disease Control and Prevention updated their sexually transmitted infections treatment guidelines with important considerations for women’s health providers, such as new recommendations for Neisseria gonorrhoeae, Chlamydia trachomatis, Trichomonas vaginalis, pelvic inflammatory disease, and Mycoplasma genitalium.